Amgen Stock Sees Massive Institutional Buying Spree
Summitry LLC significantly increased its holdings in Amgen Inc. (NASDAQ:AMGN) by 8,394.5% during the first quarter. The institutional investor now owns 73,732 shares of the medical research company's stock after buying an additional 72,864 shares.
The value of Summitry LLC's holdings in Amgen was $25,942,000 as of its most recent filing with the Securities and Exchange Commission. This is not an isolated instance, as several other institutional investors have also recently purchased or increased their stakes in Amgen.